Yahoo Web Search

Search results

1. • 

     How Atrium Health Wake Forest Baptist team member’s heart condition inspired a career in research -...

     The Business Journals· 6 days ago

     Stephanie Bowden was only 11 years old when she was diagnosed with hypertrophic cardiomyopathy...

2. • Tenaya Therapeutics (NASDAQ:TNYA) PT Lowered to $16.00 at Canaccord Genuity Group

     ETF DAILY NEWS· 21 hours ago

     Tenaya Therapeutics (NASDAQ:TNYA – Free Report) had its target price trimmed by Canaccord Genuity Group from $18.00 to $16.00 in a research report report published on Thursday morning, Benzinga ...

3. • Lifesci Capital Comments on Tenaya Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:TNYA)

     ETF DAILY NEWS· 1 day ago

     Tenaya Therapeutics, Inc. (NASDAQ:TNYA – Free Report) – Investment analysts at Lifesci Capital issued their Q2 2024 earnings per share estimates for shares of Tenaya Therapeutics in a research ...

4. • 

     Camzyos and cost: Reducing long-term drug costs and more

     Medical News Today· 6 days ago

     The cost of the drug with and without insurance can depend on several factors, such as whether...

5. • Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...

     Morningstar· 7 days ago

     Analyses of SEQUOIA-HCM Elaborate on Dosing and Measures of Safety During Treatment with Aficamten Results from Cardiopulmonary Exercise Testing Showed Improvement in Exercise Performance were ...

6. • 

     Health Care Roundup: Market Talk

     The Wall Street Journal· 5 days ago

     Mizuho analyst Salim Syed says in a research note that investors have focused on data from aficamten, a potential treatment for hypertrophic ...

7. • 

     Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos

     FierceBiotech· 6 days ago

     Having reported primary endpoint success in December 2023, the biotech rolled into the European...

8. • 

     Health Care Roundup: Market Talk

     The Wall Street Journal· 6 days ago

     According to Mizuho analyst Salim Syed, more extensive data from Cytokinetics’s aficamten, a potential treatment for hypertrophic cardiomyopathy, shows...

9. • How Toxins Can Cause Heart Failure and Cardiomyopathy

     Mercola· 5 days ago

     According to research1 published in 1999, people with severe heart failure have 12,000-fold more antimony in their myocytes (the heart muscle cells responsible for contraction) than healthy ...

10. • Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle...

      Morningstar· 3 days ago

      “We are proud to convene the CLIMB Research Symposium, a unique forum for the muscle biology community, including academic researchers and students, to engage in scientific discussion and share ...